Announcement no. 22/2022
Operations related to the share buyback program
On
The objective of the program is to reduce the Company’s share capital and adjust the capital structure by distributing capital to shareholders in accordance with the Company’s capital structure and capital allocation policy. The Program will end no later than
The following transactions were made under the program during the period
Transactions | ||||
Date | Number of actions | Avg. purchase price in DKK | Transaction value in DKK | |
1,606 | 39.55 | 63,513 | ||
26,020 | 40.37 | 1,050,524 | ||
11,765 | 39.86 | 468,940 | ||
10,537 | 39.63 | 417 610 | ||
18,610 | 40.01 | 744 541 | ||
Total | 68,538 | 40.05 | 2,745,128 |
Össur acquired 407,992 shares under the Program at an average price of
The Nasdaq Copenhagen Program is conducted pursuant to Regulation No. 596/2014 of the
More information
Edda Lára Lúðvígsdóttir, Director of Investor Relations, [email protected], +354 844 4759
Össur press releases by e-mail
If you would like to receive Össur press releases by email, please sign up at http://www.ossur.com/investors
About Ossur
Össur (Nasdaq Copenhagen: OSSR) is a global leader in noninvasive orthopedics that helps people live lives without limits. A recognized “technology pioneer” with a rich 50-year history, Össur focuses on improving people’s mobility through the provision of innovative technologies in prosthetics and splints and supports. Significant investments in research and development have led to over 2,000 patents, award-winning designs, successful clinical results and consistently strong market positions. Össur is a signatory of the
https://news.cision.com/ossur-hf-/r/ossur-hf–transactions-in-relation-to-share-buyback-program,c3544029
https://mb.cision.com/Main/18404/3544029/1562747.pdf
(c) Decision 2022. All rights reserved., sources